Table Of Contents
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Overview
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Female Infertility Market: By Product & Services Segment Market Trends, Size, and Future Outlook
- By Product & Services Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
- By Product & Services Segment Definitions, Technology Landscape
- By Product & Services Segment Market Drivers
- New product launches
- Technological advancements
- Rising demand
- By Product & Services Segment Market Restraints
- High costs
- Low awareness in developing regions
- Stringent regulations
Chapter 4. Female Infertility Market: By Procedure Segment Market Trends, Size, and Future Outlook
- By Procedure Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
- By Procedure Segment Definitions, Technology Landscape
- By Procedure Segment Market Drivers
- Increasing preference for IVF
- Rising fertility tourism
- Favorable regulations
- By Procedure Segment Market Restraints
- Risks associated with ART
- Limitations in insurance coverage
- Ethical concerns
Chapter 5. Female Infertility Market: By End User Segment Market Trends, Size, and Future Outlook
- By End User Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
- By End User Segment Definitions, Technology Landscape
- By End User Segment Market Drivers
- Establishment of new fertility clinics
- Rising hospital investments
- Growth of medical tourism
- By End User Segment Market Restraints
- High operating costs for clinics
- Shortage of trained professionals
- Limitations in developing regions
Chapter 6. Female Infertility Market: Regional Market Trends, Size, and Future Outlook
- North America
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2022-2030)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Supportive government policies
- Growing target population
- Strong presence of key players
- North America Market Restraints
- Stringent regulatory landscape
- Limitations in reimbursement
- Higher treatment costs
- Europe
- Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Supportive government policies
- Growing target population
- Strong presence of key players
- Europe Market Restraints
- Stringent regulatory landscape
- Limitations in reimbursement
- Higher treatment costs
- Asia Pacific
- Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Supportive government policies
- Growing target population
- Strong presence of key players
- Asia Pacific Market Restraints
- Stringent regulatory landscape
- Limitations in reimbursement
- Higher treatment costs
- Latin America
- Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Supportive government policies
- Growing target population
- Strong presence of key players
- Latin America Market Restraints
-
- Stringent regulatory landscape
- Limitations in reimbursement
- Higher treatment costs
-
- Middle East & Africa
- Middle East & Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Supportive government policies
- Growing target population
- Strong presence of key players
- Middle East & Africa Market Restraints
-
- Stringent regulatory landscape
- Limitations in reimbursement
- Higher treatment costs
-
Chapter 7. Female Infertility Market: Competitive Landscape
- CooperSurgical
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Cook Medical
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Vitrolife
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Thermo Fisher Scientific
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Esco Micro
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Genea Biomedx
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- FUJIFILM Irvine Scientific
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- IVFtech
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Kitazato
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
- Rocket Medical
- Company Overview
- Financial Overview
- Product Portfolio
- Recent Developments
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the female infertility industry is US$ 19.4 billion in 2023.
Rising rates of infertility globally, Delayed pregnancies and advanced maternal age, Changing lifestyles and rise of reproductive disorders
High cost, low awareness in developing countries, risks involved in ART procedures, restrictive regulations, lack of insurance coverage, social stigma, limited funding and reimbursements.
The media and consumables segment (used in IVF and fertility treatments).
CooperSurgical, Cook Medical, Vitrolife, Thermo Fisher Scientific, Esco Micro, Genea Biomedx, FUJIFILM Irvine Scientific, IVFtech, Kitazato, Rocket Medical are the major players.
The Female Infertility Market is expected to grow at a CAGR of 6.1% from US$ 19.4 billion in 2022 to US$ 29.3 billion by 2030.
Rising infertility rates, delayed pregnancies, favorable government initiatives, emerging treatments like IVF, and increasing cases of lifestyle disorders leading to infertility.